Copyright
©The Author(s) 2021.
World J Clin Cases. Feb 16, 2021; 9(5): 1079-1086
Published online Feb 16, 2021. doi: 10.12998/wjcc.v9.i5.1079
Published online Feb 16, 2021. doi: 10.12998/wjcc.v9.i5.1079
Characteristics | Patient 1 | Patient 2 | Patient 3 |
Sex | Male | Male | Male |
Age | 29 | 33 | 26 |
Manifestation of the skin eruptions | Grey-black changes on the face, intensive distribution of yellow to brownish, miliary to mung bean-sized papules and nodules were seen over the head, face, neck, torso, armpit, lower limb, hips, and perineum; some lesions were covered with pus plugs and blackheads; some lesions were fused | Intensive distribution of yellow to brownish, miliary to mung bean-sized papules and nodules were seen over the head and face; some lesions were covered with pus plugs and blackheads; similar lesions were distributed discretely over the other body parts | Intensive distribution of yellow to brownish, miliary to mung bean-sized papules and nodules over the face, neck, and chest were observed; some lesions were covered with pus plugs and blackheads; similar lesions were distributed discretely over the other body parts |
Time to skin lesion | 3 d | 1 wk | 2 wk |
Neurological damages | Bilateral calf pain | None | Bilateral calf pain |
Ocular symptoms | Increased eye secretions with itching, and difficulty to keep eye open | None | None |
Gastrointestinal symptoms | Nausea, but no abdominal pain, diarrhea, or vomiting | None | None |
Liver function | ALT 20105.30 U/L, AST 8074.50 U/L (significantly increased AST) | ALT 45.30 U/L, AST 38.80 U/L (normal) | ALT 23453.40 U/L, AST 9735.23 U/L (significantly increased AST) |
Routine blood test | WBC 23.20 × 109/L, NE% 93.80% | Normal | WBC 21.40 × 109/L, NE% 89.70% |
Liver function (3 mo later) | ALT 22.70 U/L, AST 28.50 U/L | ALT 31.10 U/L, AST 20.80 U/L | ALT 35.20 U/L, AST 54.90 U/L |
Routine blood test (3 mo later) | WBC 8.58 × 109/L, NE% 78.74% | WBC 7.22 × 109/L | WBC 9.43 × 109/L |
Treatments | Valentate, mecobalamin, oral mediaction with diclofenac sodium and codeine phosphate tablet, and topical use of adapalene gel | Valentate, mecobalamin, oral mediaction with diclofenac sodium and codeine phosphate tablet, and topical use of adapalene gel | Valentate, mecobalamin, oral mediaction with diclofenac sodium and codeine phosphate tablet, and topical use of adapalene gel |
Current status (1 yr later) | Newly occurring rashes are still seen intermittently on the neck | Skin eruptions on the face have subsided at present | Skin eruptions on the face have subsided at present |
- Citation: Ma Y, Cao X, Zhang L, Zhang JY, Qiao ZS, Feng WL. Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases. World J Clin Cases 2021; 9(5): 1079-1086
- URL: https://www.wjgnet.com/2307-8960/full/v9/i5/1079.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i5.1079